Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment

BACKGROUND: The purpose of this study was to evaluate intravitreal bevacizumab as an adjuvant treatment to plaque brachytherapy in the treatment of choroidal melanoma. METHODS: This was a retrospective, consecutive study of 124 patients treated from 2007 to 2009 for choroidal melanoma with plaque br...

Descripción completa

Detalles Bibliográficos
Autores principales: Houston, Samuel K, Shah, Nisha V, Decatur, Christina, Lonngi, Marcela, Feuer, William, Markoe, Arnold M, Murray, Timothy G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557102/
https://www.ncbi.nlm.nih.gov/pubmed/23378737
http://dx.doi.org/10.2147/OPTH.S37938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557102/
https://www.ncbi.nlm.nih.gov/pubmed/23378737
http://dx.doi.org/10.2147/OPTH.S37938

Ejemplares similares